Table 1.
Guidelines for the reporting of clinical research data in the Journal of Pediatric Surgery
| Reported | Not applicable | Reporting detail |
|---|---|---|
| Methods | ||
| □ | ⊠ | The no. and practice type of all institutions where cases were performed |
| □ | ⊠ | The no. of surgeons who actually operated in the study (and the relative number of cases for each) |
| □ | ⊠ | The prior experience of participating surgeons in performing the reported intervention |
| ⊠ | □ | The precise timeline during which all patients were treated in the study (eg, Jan 1995 to March 1998) |
| ⊠ | □ | A clear description of how patients were selected into the study. This should include relevant inclusion and/or exclusion criteria. |
| ⊠ | □ | The no. of eligible patients at the study sites excluded during the timeline of the study |
| ⊠ | □ | A clear description of the study population from which the patients were selected. |
| ⊠ | □ | A clear description of the relevant diagnostic criteria used to identify cases |
| □ | ⊠ | A clear description of critical aspects of operative technique and perioperative care |
| □ | ⊠ | Statement as to whether any attempts were made to standardize operative technique or perioperative care (and how this was accomplished). |
| Results | ||
| ⊠ | □ | The range and mean of all relevant demographic and baseline variables |
| □ | ⊠ | The range and median (not mean) for length of follow-up reporting |
| ⊠ | □ | Relevant outcome variables are presented with appropriate measures of range and variability (eg, SD) |
| ⊠ | □ | Methods for measuring outcomes of interest are clearly described |
| ⊠ | □ | Statement regarding whether any data are missing (and how missing data are addressed in the analysis of outcome variables) |
| □ | ⊠ | No. and appropriate details regarding all complications |
| Additional details for studies reporting more than 1 treatment group (eg, controls) | ||
| □ | ⊠ | Mean and range for all relevant demographic and baseline variables for all treatment groups. |
| □ | ⊠ | The range and median (not mean) for length of follow-up reporting for each treatment group |
| □ | ⊠ | A precise timeline during which all patients were treated for each group |
| □ | ⊠ | Outcome variables being compared between groups are presented with appropriate measures of variability (eg, SD) |
| □ | ⊠ | Measures of type II error (P values) for comparison statistics are presented with actual values if P = .01 or larger (eg, P = NS and P < .05 are not acceptable) |
| □ | ⊠ | A description of how patients were selected into each treatment group |
| □ | ⊠ | A statement is made as to whether the same surgeons operated on patients from different treatment groups |
Articles concerning clinical research should follow a uniform set of reporting guidelines. The guidelines, listed above, were developed from sound clinical research principles and are designed to improve the reporting accuracy of clinical data pertaining to surgical conditions.
With more accurate and transparent reporting of study methodology and outcomes data, readers of the Journal will be better able to gauge the relevance of reported results to their own clinical practice. Although not all of the recommended reporting guidelines below are applicable to every clinical study, it is important that all details relevant to your study are clearly reported in the article. Please check the appropriate boxes below to verify compliance with these guidelines, and return this sheet with the article at the time of submission. Compliance with these guidelines in combination with subsequent content revisions will be considered by the editor in the final decision regarding publication of your article.
NS indicates not significant.